Following promising trial data , retatrutide, a novel peptide therapy for managing non-insulin dependent hyperglycemia , has received regulatory approval from UK’s Drug and Healthcare Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/